BOVINE-DERIVED MATERIAL USE IN FDA-REGULATED PRODUCTS
This article was originally published in The Rose Sheet
Executive Summary
BOVINE-DERIVED MATERIAL USE IN FDA-REGULATED PRODUCTS intended for administration to humans should be limited to products from cattle which have not "resided in or originated from countries where bovine spongiform encephalopathy (BSE) has been diagnosed," FDA Deputy Commissioner for Operations Jane Henney said in a Dec. 17 letter to manufacturers.